Daiichi-Biota Drug Proves Equal To Tamiflu In Single-Dose Version
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo's CS-8958 (laninamivir) antiviral developed with Australia's Biota for treating influenza through an inhaler has been shown the equal of one of the most popular flu treatments